Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China
· Delayed Price · Currency is CNY 10.74
-0.01 (-0.09%)
Jun 6, 2025, 2:45 PM CST
SHA:600420 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,114 | 1,084 | 691.88 | 627.79 | 568.28 | 648.79 | Upgrade
|
| Depreciation & Amortization | 766.23 | 766.23 | 818.89 | 842.49 | 820.27 | 726.41 | Upgrade
|
| Other Amortization | 12.07 | 12.07 | 6.36 | 6.06 | 10.48 | 10.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | 31.31 | 31.31 | 31.85 | 1.1 | -0.2 | -23.92 | Upgrade
|
| Asset Writedown & Restructuring Costs | 28.26 | 28.26 | 13.13 | 3.43 | 135.66 | 47.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | -64.11 | -64.11 | -27.45 | -2.34 | 24.04 | 21.81 | Upgrade
|
| Provision & Write-off of Bad Debts | -2.36 | -2.36 | -18.05 | -17.59 | 24.87 | 26.24 | Upgrade
|
| Other Operating Activities | -9.29 | 427.46 | 399.15 | 393.7 | 405.67 | 405 | Upgrade
|
| Change in Accounts Receivable | 732.85 | 732.85 | 485.43 | 463.12 | -921.35 | -993.23 | Upgrade
|
| Change in Inventory | 60.54 | 60.54 | 163.27 | 625.24 | 195.31 | -966.64 | Upgrade
|
| Change in Accounts Payable | -918.52 | -918.52 | -832.62 | -30.39 | 444.18 | 1,652 | Upgrade
|
| Operating Cash Flow | 1,849 | 2,256 | 1,720 | 2,856 | 1,680 | 1,560 | Upgrade
|
| Operating Cash Flow Growth | -14.47% | 31.13% | -39.76% | 70.01% | 7.66% | 22.84% | Upgrade
|
| Capital Expenditures | -216.57 | -219.77 | -357.19 | -307.44 | -521.44 | -377.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 22.56 | 21.95 | 10.96 | 5 | 3.72 | 26.02 | Upgrade
|
| Investment in Securities | 3.29 | 3 | 2.01 | - | 1.14 | -207.81 | Upgrade
|
| Other Investing Activities | -818.11 | -661.4 | -1,019 | - | 8.31 | 2.68 | Upgrade
|
| Investing Cash Flow | -1,009 | -856.23 | -1,363 | -302.44 | -508.28 | -557.09 | Upgrade
|
| Long-Term Debt Issued | - | 50 | 45 | 2,346 | 3,685 | 3,304 | Upgrade
|
| Total Debt Issued | 50 | 50 | 45 | 2,346 | 3,685 | 3,304 | Upgrade
|
| Long-Term Debt Repaid | - | -61.44 | -774.23 | -3,203 | -3,402 | -4,077 | Upgrade
|
| Total Debt Repaid | -1,061 | -61.44 | -774.23 | -3,203 | -3,402 | -4,077 | Upgrade
|
| Net Debt Issued (Repaid) | -1,011 | -11.44 | -729.23 | -856.83 | 282.87 | -773.63 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,188 | - | - | Upgrade
|
| Common Dividends Paid | -300.47 | -300.68 | -189.35 | -184.7 | -212.46 | -210.32 | Upgrade
|
| Other Financing Activities | -172.69 | -103.3 | -174.8 | -581.78 | -732.81 | -981.42 | Upgrade
|
| Financing Cash Flow | -1,485 | -415.42 | -1,093 | -435.32 | -662.41 | -1,965 | Upgrade
|
| Foreign Exchange Rate Adjustments | 39.31 | 29.63 | 32.07 | 94.24 | -40.08 | -44.35 | Upgrade
|
| Net Cash Flow | -604.73 | 1,014 | -703.83 | 2,212 | 468.9 | -1,007 | Upgrade
|
| Free Cash Flow | 1,633 | 2,036 | 1,363 | 2,548 | 1,158 | 1,182 | Upgrade
|
| Free Cash Flow Growth | -13.17% | 49.37% | -46.50% | 120.01% | -2.03% | 36.46% | Upgrade
|
| Free Cash Flow Margin | 15.67% | 18.62% | 11.29% | 19.66% | 8.31% | 9.41% | Upgrade
|
| Free Cash Flow Per Share | 1.22 | 1.52 | 1.07 | 2.20 | 0.98 | 1.00 | Upgrade
|
| Cash Income Tax Paid | 608.94 | 693.04 | 751.63 | 617.65 | 696.29 | 701.8 | Upgrade
|
| Levered Free Cash Flow | -98.79 | 1,668 | 1,796 | 1,634 | 621.88 | -96.55 | Upgrade
|
| Unlevered Free Cash Flow | -80.78 | 1,691 | 1,832 | 1,701 | 690.92 | -19.36 | Upgrade
|
| Change in Net Working Capital | 1,591 | -172.95 | -759.77 | -633.75 | 292.15 | 1,062 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.